Comparison of percutaneous nephrostomy versus DJ stent in early normalization of renal function test in obstructive uropathy secondary to urolithiasis
DOI:
https://doi.org/10.55629/pakjpathol.v36i3.922Abstract
Objective: To compare the pathological and clinical outcomes of percutaneous nephrostomy (PCN) versus double-J (DJ) stent placement in restoring renal function in obstructive uropathy secondary to urolithiasis, focusing on mechanisms of tubular injury, fibrosis, and inflammatory response.
Material and Methods: A randomized clinical trial (March–September 2023) included 200 patients (100 PCN, 100 DJ stent) with obstructive uropathy due to urolithiasis. Inclusion criteria: age 18–75 years, elevated serum creatinine (>1.03 mg/dL males; >1.1 mg/dL females), and urea (>20 mg/dL). Renal function normalization time (hours) was measured post-intervention. Quantitative variables (age, stone size/duration, BMI) were analyzed using independent t-test/Mann-Whitney U test. Pathological correlates included TGF-β-mediated fibrosis, angiotensin II activity, and mononuclear leukocyte infiltration.
Results: PCN demonstrated significantly faster renal recovery (100.20 (15.41) hours vs. DJ stent: 109.40 (15.15) hours, p=0.001). Stratified analysis revealed prolonged obstruction (>10 days) exacerbated interstitial fibrosis in DJ stent patients (117.29 (7.67) hours vs. PCN: 108.14 (7.75) hours, p=0.001). Diabetic patients exhibited delayed normalization (PCN: 106.17 (6.52) hours; DJ: 117.00 (8.25) hours, p=0.001), correlating with heightened oxidative stress.
Conclusion: PCN accelerates renal function recovery by mitigating pathological cascades (ischemia, TGF-β-driven fibrosis, and cytokine release) more effectively than DJ stents. These findings highlight the role of rapid decompression in reducing chronic tubulointerstitial damage.
Keywords: Inflammatory cytokines, Obstructive uropathy, Percutaneous nephrostomy, Renal ischemia, Tubulointerstitial fibrosis, Urolithiasis.
References
Türk C, Petřík A, Sarica K, Seitz C, Skolarikos A, Straub M, et al. EAU guidelines on diagnosis and conservative management of urolithiasis. Eur Urol. 2016; 69(3): 468-74. DOI: https://doi.org/10.1016/j.eururo.2015.07.040
Saeed K, Hussain SA, Kanjoo SR, Ahmad B, Hussain M. Double-J stenting versus percutaneous nephrostomy. Ann Punjab Med Coll. 2020; 14(4): 336-9. DOI: https://doi.org/10.29054/apmc/2020.1108
Yaxley J, Yaxley W. Obstructive uropathy - acute and chronic medical management. World J Nephrol. 2023;12(1):1-9. doi:10.5527/wjn.v12.i1.1
Nørregaard R, Mutsaers HA, Frøkiær J, Kwon TH. Obstructive nephropathy and molecular pathophysiology of renal interstitial fibrosis. Physiol Rev. 2023;103(4):2847-2892. DOI: https://doi.org/10.1152/physrev.00027.2022
Chen TK, Knicely DH, Grams ME. Chronic kidney disease diagnosis and management. JAMA. 2019; 322(13):1294-304. DOI: https://doi.org/10.1001/jama.2019.14745
Ghasemi-Rad M, Trinh K, Wynne D, Ahmadzade M, Shamim MH, Guerrero O, et al. Nephrostomy (PCN) versus nephroureteral stent (Double JJ); An ongoing battle. Urologia J. 2025; 92(3): 424-431. DOI: https://doi.org/10.1177/03915603251316702
Ali L, Khan S, Khan FH, Orakzai N. Comparison of PCN and DJ stent in renal recovery. Ann PIMS. 2020; 16(1): 10-14.
DOI: https://doi.org/10.48036/apims.v16i1.301
Khan SA, Kumar N, Bux K, Chachar MA, Bangwarah AK. Comparison efficacy between percutaneous nephrostomy and double J stent in management of obstructive uropathy. J Health Rehabil Res. 2024; 4(1): 1339-1342.
DOI: https://doi.org/10.61919/jhrr.v4i1.627
Naeem M, Jan MA, Ullah A, Ali L, Khan S, Haq A, et al. Percutaneous nephrostomy for tHE relief of upper urinary tract obstruction: an experience with 200 cases. J Postgrad Med Inst. 2010; 24(2): 124-9. Available from: https://jpmi.org.pk/index.php/ jpmi/article/view/1056
Misseri R, Rink RC, Meldrum DR, et al. Inflammatory mediators and growth factors in obstructive renal injury. J Surg Res. 2004; 119(2): 149-59. DOI: https://doi.org/10.1016/j.jss.2004.03.003
Truong LD, Gaber L, Eknoyan G. Obstructive uropathy. Contrib Nephrol. 2011; 169: 311-26. DOI: https://doi.org/10.1159/000314578
Sacks SH, Aparicio SA, Bevan A, Oliver OD, Will J, Davidson AM. et al. CKD risk post-obstruction. BMJ. 1989; 298(6667): 156-9. DOI: https://doi.org/10.1136/bmj.298.6667.156
Moon YJ, Jun DY, Jeong JY, Cho S, Lee JY, Jung HD. Percutaneous nephrostomy versus ureteral stent for severe urinary tract infection with obstructive urolithiasis: A systematic review and meta-analysis. Medicina. 2024; 60(6): e861. DOI: https://doi.org/10.3390/medicina60060861
Sutariya B, Jhonsa D, Saraf MN. TGF-β: The connecting link between nephropathy and fibrosis. Immunopharmacol Immunotoxicol. 2016; 38(1): 39-49. DOI:https://doi.org/10.3109/08923973.2015.1127382
Pigatto Filho G, Nichele SA, de Oliveira FV, Santos LS, de Fraga R. Time-sensitive elements in elective treatment of urinary lithiasis: A narrative review. Transl Androl Urol. 2025; 14(1): e181. DOI: https://doi.org/10.21037/tau-24-596
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Muhammad Idrees Hanif, Hafiz Dur-e-Furqani, Rashid Zia, Amr Abdullah Ahmed Shaddad, Abdul Rehman, Syed Rafiuddin Shah

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Readers may “Share-copy and redistribute the material in any medium or format” and “Adapt-remix, transform, and build upon the material”. The readers must give appropriate credit to the source of the material and indicate if changes were made to the material. Readers may not use the material for commercial purpose. The readers may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
